Massivemarkets

SLS

SELLAS Life Sciences Group, Inc. Common Stock

Nasdaq · usd

$13.66-1.20 (-8.08%)
At close · 15-minute delayed
$14.26+0.59 (+4.36%)
As of 7:59:30 PM EST on Nov 20, 2026 · After hours

SELLAS Life Sciences Group, Inc. Common Stock (SLS) trades at $13.66 (-8.08%) as of 7:59:30 PM EST on Nov 20, 2026, +20.35% over the past month. Market cap is $2.78B, with 6.7 days to cover in short interest.

Stock performance

How SELLAS Life Sciences Group, Inc. Common Stock (SLS) stock has performed from one day to one year, with its 52-week range.

-4.50%
-$0.67 over 1D
$13.53$14.06$14.58$15.114:00 AM8:55 AM12:35 PM4:20 PM8:00 PM$14.21
1D
-8.08%
1W
+73.79%
1M
+20.35%
YTD
+262.33%
1Y
+781.29%
52-wk range
$1.39 – $24.89

Key statistics

Today's trading snapshot for SLS: day range, open, previous close, volume and market cap.

Day range
$13.39 – $15.19
Open
$14.98
Prev close
$14.86
Volume
15.48M
Market cap
$2.78B
Shares out
201.95M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for SELLAS Life Sciences Group, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
—
P/B
21.13
P/FCF
—
ROE
-27.1%
ROA
-25.4%
Debt/Equity
0.00
Div yield
0.00%

As of Nov 20, 2026

8-K filings

Material corporate events SELLAS Life Sciences Group, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • Underwriting agreementNov 20, 2026

    On November 18, 2026, SELLAS Life Sciences Group, Inc. ... entered into an underwriting agreement ... with J.P. Morgan Securities LLC and TD Securities (USA) LLC, as representatives of the several underwriters named therein.

  • In the trial, GPS showed a 41% reduction in the risk of death (hazard ratio of 0.59) and a two-sided p=0.035 with a median OS of 24.0 months among GPS-treated patients versus 14.7 months with BAT.

  • Quarterly earningsNov 12, 2026

    On November 12, 2026, SELLAS Life Sciences Group, Inc. ("SELLAS") issued a press release (the "Press Release") announcing its financial results for the quarter ended September 30, 2026 and providing a corporate update.

  • Material litigationJul 27, 2026

    On July 24, 2026, the sole arbitrator in the arbitration proceeding rendered a decision dismissing the Company's claims. As permitted by HKIAC rules, the arbitrator administratively allocated a portion of 3D Medicines' legal fees and costs in the amount of approximately $1.0 million to be paid by the Company.

  • Executive compensation changeJun 25, 2026

    The Stergiou Amendment amends the Stergiou Employment Agreement to provide that certain payments made to Dr. Stergiou as part of his change in control severance benefits will be paid in a lump sum payment.

Dividend history and stock splits

SELLAS Life Sciences Group, Inc. Common Stock's recent dividend payments and stock splits.

Dividends

  • $0.24ex-div Mar 24, 2011
  • $0.42ex-div Dec 9, 2010
  • $0.15ex-div Sep 9, 2010
  • $0.09ex-div Jun 10, 2010

Splits

  • 1-for-50Nov 8, 2019
  • 1-for-20Nov 14, 2016

SLS short interest

How heavily SLS is shorted: shares short, days to cover and average daily volume.

Days to cover
6.7
Short interest
57.13M
Avg volume
8.53M

As of · reported to FINRA twice monthly.

SLS news

The latest news and headlines about SELLAS Life Sciences Group, Inc. Common Stock (SLS).

Frequently asked questions

What is the SELLAS Life Sciences Group, Inc. Common Stock (SLS) stock price today?

SELLAS Life Sciences Group, Inc. Common Stock (SLS) is trading at $13.66 (-8.08% on the day) as of 7:59:30 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is SELLAS Life Sciences Group, Inc. Common Stock?

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications.

What is the short interest in SLS?

As of Oct 30, 2026, SLS has 57.13M shares short and 6.7 days to cover.

Does SELLAS Life Sciences Group, Inc. Common Stock (SLS) pay a dividend?

Yes. SELLAS Life Sciences Group, Inc. Common Stock (SLS)'s most recent dividend was $0.24 per share, with an ex-dividend date of Mar 24, 2011. Full SLS dividend history is available from the Massive API.

What exchange is SLS listed on?

SELLAS Life Sciences Group, Inc. Common Stock (SLS) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of SLS with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a SLS analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.